Announcement on Results of Issuing Phase II Ultra-Short-Term Financing Bonds of 2026

About this update from Jointown Pharmaceutical Group Co., Ltd. Class A

Announcement on Results of Issuing Phase II Ultra-Short-Term Financing Bonds of 2026 The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Jointown Pharmaceutical Group Co., Ltd. Class A